Duncker Streett & Co’s West Pharmaceutical WST Stock Holding History

Duncker Streett & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-130	Closed	-$13K	–	617
2017 Q3	$13K	Hold	130	–	–	﹤0.01%	492
2017 Q2	$12K	Hold	130	–	–	﹤0.01%	504
2017 Q1	$11K	Hold	130	–	–	﹤0.01%	529
2016 Q4	$11K	Hold	130	–	–	﹤0.01%	525
2016 Q3	$10K	Sell	130 -100	-43%	-$7.94K	﹤0.01%	515
2016 Q2	$17K	Hold	230	–	–	0.01%	463
2016 Q1	$16K	Hold	230	–	–	0.01%	471
2015 Q4	$14K	Hold	230	–	–	0.01%	487
2015 Q3	$12K	Hold	230	–	–	﹤0.01%	499
2015 Q2	$13K	Hold	230	–	–	﹤0.01%	505
2015 Q1	$14K	Hold	230	–	–	﹤0.01%	506
2014 Q4	$12K	Hold	230	–	–	﹤0.01%	511
2014 Q3	$10K	Buy	230 +30	+15%	+$1.27K	﹤0.01%	524
2014 Q2	$8K	Buy	200 +100	+100%	+$4.28K	﹤0.01%	543
2014 Q1	$4K	Hold	100	–	–	﹤0.01%	545
2013 Q4	$5K	Hold	100	–	–	﹤0.01%	524
2013 Q3	$4K	Hold	100	–	–	﹤0.01%	524
2013 Q2	$4K	Buy	+100	New	+$3.29K	﹤0.01%	518

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Duncker Streett & Co's WST Position: Q4 2017 in Review

Duncker Streett & Co sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 130 shares — an estimated $13K sold.

Duncker Streett & Co first reported a position in WST in Q2 2013 and held it in 18 quarters. The position peaked at $17K in Q2 2016. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

Duncker Streett & Co reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
Duncker Streett & Co sold 130 West Pharmaceutical shares in Q4 2017, an estimated $13K.
Duncker Streett & Co first reported a position in West Pharmaceutical in Q2 2013 and held it in 18 quarters.
Duncker Streett & Co's West Pharmaceutical position peaked at $17K in Q2 2016.
338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Duncker Streett & Co's 13F filing for Q4 2017, filed 23 Jan 2018.